The proline plasma levels have been shown to be increased in patients with T2DM, obesity, and insulin resistance; such persistent alterations lead ultimately to impaired insulin secretion, systemic glucose homeostasis disruption, and other dysfunctions (Liu et al. 2016). This evidence concerns the gene INS and obesity due to melanocortin 4 receptor deficiency.